The effect of soy protein beverages on serum cell adhesion molecule concentrations in prehypertensive/stage 1 hypertensive individuals
- PMID: 22855915
- DOI: 10.1080/07315724.2012.10720015
The effect of soy protein beverages on serum cell adhesion molecule concentrations in prehypertensive/stage 1 hypertensive individuals
Abstract
Objective: Prehypertensive and hypertensive individuals are at increased risk of atherosclerotic cardiovascular disease (CVD), in part because hypertension contributes to endothelial dysfunction and increased cell adhesion molecule expression. Soy protein and isoflavones may favorably alter CVD risk factors, and hence the aim of this study was to determine whether intake of cow's milk compared with soy beverage prepared from whole soy bean (WSB) or soy protein isolate (SPI) would lower soluble cell adhesion molecule concentrations as a means of decreasing CVD risk.
Methods: We enrolled healthy prehypertensive/stage 1 hypertensive men (n = 60; 18-63 years) and premenopausal women (n = 8; 20-48 years). Participants were randomized to 1 of 3 groups for 8 weeks: cow's milk (600 mL/d), SPI beverage (840 mL/d; 30.1 mg total isoflavones/d), or WSB beverage (840 mL/d; 91.4 mg total isoflavones/d). We measured soluble vascular cell adhesion molecule-1 (VCAM-1), intercellular cell adhesion molecule-1 (ICAM-1), and endothelial-leukocyte adhesion molecule-1 (E-selectin) concentrations at baseline and week 8.
Results: Soluble CAM concentrations were not altered by treatment and did not differ between prehypertensive and hypertensive participants. However, analysis of variance indicated a treatment × gender interaction (gender effect) for ICAM-1 (p = 0.0037) but not for E-selectin (p = 0.067) or VCAM-1 (p = 0.16). Men had higher concentrations of ICAM-1 and E-selectin, respectively, at baseline (p = 0.0071, p = 0.049) and week 8 (p = 0.0054, p = 0.038) than women did.
Conclusion: Neither intake of cow's milk nor soy beverage for 8 weeks altered soluble CAM concentrations in prehypertensive/stage 1 hypertensive individuals, suggesting that neither type of beverage diminished atherosclerotic CVD risk in mildly hypertensive individuals by way of improving circulating CAM concentrations.
Similar articles
-
Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women.Eur J Clin Nutr. 2008 Dec;62(12):1419-25. doi: 10.1038/sj.ejcn.1602885. Epub 2007 Sep 5. Eur J Clin Nutr. 2008. PMID: 17805230 Clinical Trial.
-
Effects of oral soy protein on markers of inflammation in postmenopausal women with mild hypercholesterolemia.Am Heart J. 2003 Feb;145(2):e7. doi: 10.1067/mhj.2003.115. Am Heart J. 2003. PMID: 12595862 Clinical Trial.
-
Effects of soy isoflavones on endothelial function in healthy postmenopausal women.Menopause. 2005 May-Jun;12(3):299-307. doi: 10.1097/01.gme.0000147017.23173.5b. Menopause. 2005. PMID: 15879919 Clinical Trial.
-
The effect of soy protein containing soy isoflavones on serum concentration of cell adhesion molecules: A systematic review and meta-analysis of randomized controlled trials.Complement Ther Med. 2021 Sep;61:102764. doi: 10.1016/j.ctim.2021.102764. Epub 2021 Jul 29. Complement Ther Med. 2021. PMID: 34333131 Review.
-
Technical opinion of the Asociación Mexicana de Gastroenterología on soy plant-based beverages.Rev Gastroenterol Mex (Engl Ed). 2020 Oct-Dec;85(4):461-471. doi: 10.1016/j.rgmx.2020.07.005. Epub 2020 Aug 27. Rev Gastroenterol Mex (Engl Ed). 2020. PMID: 32863095 Review. English, Spanish.
Cited by
-
Effects of Vegetables on Cardiovascular Diseases and Related Mechanisms.Nutrients. 2017 Aug 10;9(8):857. doi: 10.3390/nu9080857. Nutrients. 2017. PMID: 28796173 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous